Sana Biotechnology Inc (SANA)

Sana Biotechnology Inc (SANA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $835M; returns 1 day -1.7%, 1 week +2.6%, 1 year -58.3%.

Sana Biotechnology Inc. (SANA) is a clinical-stage biotechnology company focused on developing engineered cell therapies. As of January 2026, the company generates no revenue from product sales, with its business model entirely reliant on raising capital and securing funding to support its extensive research and development (R&D) activities.

Groups SANA belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Clinical Stage
• R&D
• Gene Therapy
• Type 1 Diabetes
• Autoimmune Diseases
• Life Sciences
• Biopharmaceutical
• Oncology
• Immunotherapy

SANA financial model: income statement, cash flow and balance sheet